Commentary

Buprenorphine offers a way to rise from the ashes of addiction


 

References

One of the most rewarding aspects of being a physician is having a direct impact on alleviating patient suffering. On the other hand, one of the more difficult elements is a confrontational patient with unreasonable expectations or inappropriate demands. I have experienced both ends of the spectrum while engaging with patients who have opioid use disorder (OUD).

An untreated patient with OUD might provide an untruthful history, attempt to falsify exam findings, or even become threatening or abusive in an attempt to secure opiate pain medication. Managing a patient with OUD by providing buprenorphine treatment, however, is a completely different experience.

Personally, I’ve found offering buprenorphine treatment to be one of the most rewarding aspects of practicing medicine.

There is no controversy about the effectiveness of buprenorphine treatment for OUD. Patients seeking it are not looking for inappropriate care but rather a treatment that is established as an unequivocal standard with proven results for better treatment outcomes1-3 and reduced mortality.4 Personally, I’ve found offering buprenorphine treatment to be one of the most rewarding aspects of practicing medicine. It is a real joy to witness people turn their lives around with meaningful outcomes such as gainful employment, eradication of hepatitis C, reconciliation of broken relationships, resolution of legal troubles, and long-term sobriety. Being a part of lives that are practically resurrected from the ashes of addiction by prescribing medicine is indeed an exceptional experience.

On April 28, 2021, the Department of Health and Human Services provided notice for immediate action allowing for any DEA-­licensed provider to obtain an X-waiver to treat 30 active patients without educational prerequisite or certification of behavioral health referral capacity.5 The X-waiver requirements were reduced, as outlined by SAMSHA,6 to a simple online notice of intent7 that can be completed in less than 5 minutes.

I encourage my colleagues to obtain the X-waiver by the simplified process, start prescribing buprenorphine, and be a part of the solution to the opioid epidemic. Of course, there will be struggles and lessons learned, but these can most certainly be eclipsed by a focus on the rewarding experience of restoring wholeness to the lives of many patients.

Aaron Newcomb, DO
Carbondale, IL

Recommended Reading

Four police suicides in the aftermath of the Capitol siege: What can we learn?
MDedge Family Medicine
Alcohol use by young adolescents drops during pandemic
MDedge Family Medicine
Self-described ‘assassin,’ now doctor, indicted for 1M illegal opioid doses
MDedge Family Medicine
EDs saw more benzodiazepine overdoses, but fewer patients overall, in 2020
MDedge Family Medicine
‘Deeper dive’ into opioid overdose deaths during COVID pandemic
MDedge Family Medicine
United Healthcare settles claims it violated mental health parity
MDedge Family Medicine
The trauma and healing of 9/11 echo in COVID-19
MDedge Family Medicine
Growing proportion of cardiac arrests in U.S. considered opioid related
MDedge Family Medicine
Opioid overdoses tied to lasting cognitive impairment
MDedge Family Medicine
As opioid deaths climb, human trials begin for vaccine
MDedge Family Medicine